RxDoctor Payments Data

Karen Contreras

Psychiatric/Mental Health · Decatur, TXNPI 1285358465

Payments from drug & device makers

$3,111in general payments, 2019–2025

Across 234 payments — averaging $13.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$575
  • AbbVie$541
  • Teva Pharmaceuticals USA, Inc.$401
  • Supernus Pharmaceuticals, Inc.$328
  • Otsuka America Pharmaceutical, Inc.$314
  • Johnson & Johnson$232
  • plus $720 from 7 others

What the payments were for

  • Food & beverage$3,07499%
  • Education$371%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,111 in reported general payments places this provider in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$26,922
Medicare patients
124
Services billed
449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine11$61,072
VraylarCariprazine Hcl36$50,867
RexultiBrexpiprazole16$34,547
Aripiprazole135$9,323
TrintellixVortioxetine Hydrobromide13$8,223
Desvenlafaxine Succinate ErDesvenlafaxine Succinate63$2,198
Bupropion XlBupropion Hcl77$1,913
Duloxetine Hcl106$1,657
Buspirone Hcl126$1,484
Venlafaxine Hcl ErVenlafaxine Hcl11$1,372
Olanzapine52$1,351
Doxepin Hcl33$1,349
Lamotrigine146$1,055
Trazodone Hcl157$879
Acamprosate Calcium11$834

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$401$61,07211 claims
AbbVieVraylar$541$50,86736 claims
Otsuka America Pharmaceutical, Inc.Rexulti$314$34,54716 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$38$8,22313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Decatur

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →